drugset

drugset / Trial / NCT01269827

Pentoxifylline and Systemic Inflammation in Hemodialysis Patients

NCT01269827 ↗

Phase 4 Completed 36 enrolled Coordinación de Investigación en Salud, Mexico

RandomizedParallel-groupDouble-blindTreatment

Summary

The aim of this study was to compare the effect of PTX vs placebo on serum concentrations of TNF-α, IL-6, and CRP in patients on hemodialysis.

Timeline

Start: 2006-01
Primary completion: 2008-05
Completion: 2008-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Pentoxifylline	Small molecule	400 mg	Oral

Indications